- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 4.50 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x 5LS- GLC- PDX: 2,3-di-O-sulfo-alpha-D-glucopyranose-(1-6)-alpha-D-glucopyranose-(1-6)-2,4-di-O-sulfo-alpha-D-glucopyranose
- 2 x 5LS- 5TJ- 5TM- 5TJ- Z4K- 5TK- 5TH: [(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4-bis(oxidanyl)-5-oxidanylsulfanyloxy-oxan-3-yl] hydrogen sulfate-(1-6)-(2S,3R,4R,5S,6R)-6-(hydroxymethyl)-5-oxidanylsulfanyloxy-oxane-2,3,4-triol-(1-6)-2-O-sulfo-alpha-D-glucopyranose-(1-6)-[(2R,3R,4R,5R,6S)-2-(hydroxymethyl)-5,6-bis(oxidanyl)-3-oxidanylsulfanyloxy-oxan-4-yl] hydrogen sulfate-(1-6)-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-2,5-bis(oxidanyl)-4-oxidanylsulfanyloxy-oxan-3-yl] hydrogen sulfate-(1-6)-[(2R,3R,4R,5R,6S)-2-(hydroxymethyl)-5,6-bis(oxidanyl)-3-oxidanylsulfanyloxy-oxan-4-yl] hydrogen sulfate-(1-6)-2,4-di-O-sulfo-alpha-D-glucopyranose
5LS-5TJ-5TM-5TJ-Z4K-5TK-5TH.3: 6 residues within 4Å:- Chain A: F.440, R.444, R.547
- Chain B: R.444, R.546, R.547
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.444, A:R.547, A:R.547
- Salt bridges: B:R.444, A:K.541
5LS-5TJ-5TM-5TJ-Z4K-5TK-5TH.9: 6 residues within 4Å:- Chain C: F.440, R.444, R.546, R.547
- Chain D: R.444, R.547
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain C- Hydrogen bonds: D:R.444, D:R.547, C:R.444, C:R.547
- Salt bridges: C:R.444, C:R.547
- 6 x 5TL: 2-azanyl-5-phenyl-3-(4-sulfamoylphenyl)benzamide(Non-covalent)
5TL.15: 14 residues within 4Å:- Chain A: L.16, G.17, T.18, V.24, M.90, E.91, Y.92, C.93, G.96, D.97, V.146, I.159, D.160
- Ligands: 5LS-GLC-PDX.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.16, A:L.16, A:V.24, A:D.97, A:I.159, A:D.160
- Hydrogen bonds: A:E.91, A:C.93, A:C.93, A:D.97, A:D.97
5TL.16: 13 residues within 4Å:- Chain B: L.16, T.18, V.24, A.37, M.90, E.91, Y.92, C.93, G.96, D.97, V.146, I.159, D.160
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:L.16, B:L.16, B:V.24, B:D.97, B:V.146, B:I.159, B:D.160
- Hydrogen bonds: B:E.91, B:C.93, B:C.93, B:D.97
5TL.17: 14 residues within 4Å:- Chain C: L.16, G.17, T.18, V.24, A.37, M.90, E.91, Y.92, C.93, G.96, D.97, V.146, I.159, D.160
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:L.16, C:L.16, C:V.24, C:V.146, C:I.159, C:D.160
- Hydrogen bonds: C:E.91, C:C.93, C:C.93, C:D.97
5TL.18: 13 residues within 4Å:- Chain D: L.16, T.18, V.24, A.37, M.90, E.91, Y.92, C.93, G.96, D.97, V.146, I.159, D.160
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:L.16, D:L.16, D:V.24, D:D.97, D:V.146, D:I.159, D:D.160
- Hydrogen bonds: D:E.91, D:C.93, D:C.93, D:D.97
5TL.19: 14 residues within 4Å:- Chain E: L.16, G.17, T.18, V.24, A.37, M.90, E.91, Y.92, C.93, G.96, D.97, V.146, I.159, D.160
11 PLIP interactions:11 interactions with chain E- Hydrophobic interactions: E:L.16, E:L.16, E:V.24, E:D.97, E:V.146, E:I.159, E:D.160
- Hydrogen bonds: E:E.91, E:C.93, E:C.93, E:D.97
5TL.20: 14 residues within 4Å:- Chain F: L.16, T.18, V.24, A.37, M.90, E.91, Y.92, C.93, G.96, D.97, V.146, I.159, D.160
- Ligands: 5LS-GLC-PDX.13
12 PLIP interactions:12 interactions with chain F- Hydrophobic interactions: F:L.16, F:L.16, F:V.24, F:D.97, F:V.146, F:I.159, F:D.160
- Hydrogen bonds: F:E.91, F:C.93, F:C.93, F:D.97, F:D.97
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Polley, S. et al., Structural Basis for the Activation of IKK1/ alpha. Cell Rep (2016)
- Release Date
- 2016-11-02
- Peptides
- Inhibitor of nuclear factor kappa-B kinase subunit alpha: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
HC
ID
JE
KF
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 4.50 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x 5LS- GLC- PDX: 2,3-di-O-sulfo-alpha-D-glucopyranose-(1-6)-alpha-D-glucopyranose-(1-6)-2,4-di-O-sulfo-alpha-D-glucopyranose
- 2 x 5LS- 5TJ- 5TM- 5TJ- Z4K- 5TK- 5TH: [(2S,3R,4S,5S,6R)-6-(hydroxymethyl)-2,4-bis(oxidanyl)-5-oxidanylsulfanyloxy-oxan-3-yl] hydrogen sulfate-(1-6)-(2S,3R,4R,5S,6R)-6-(hydroxymethyl)-5-oxidanylsulfanyloxy-oxane-2,3,4-triol-(1-6)-2-O-sulfo-alpha-D-glucopyranose-(1-6)-[(2R,3R,4R,5R,6S)-2-(hydroxymethyl)-5,6-bis(oxidanyl)-3-oxidanylsulfanyloxy-oxan-4-yl] hydrogen sulfate-(1-6)-[(2S,3R,4S,5R,6R)-6-(hydroxymethyl)-2,5-bis(oxidanyl)-4-oxidanylsulfanyloxy-oxan-3-yl] hydrogen sulfate-(1-6)-[(2R,3R,4R,5R,6S)-2-(hydroxymethyl)-5,6-bis(oxidanyl)-3-oxidanylsulfanyloxy-oxan-4-yl] hydrogen sulfate-(1-6)-2,4-di-O-sulfo-alpha-D-glucopyranose
- 6 x 5TL: 2-azanyl-5-phenyl-3-(4-sulfamoylphenyl)benzamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Polley, S. et al., Structural Basis for the Activation of IKK1/ alpha. Cell Rep (2016)
- Release Date
- 2016-11-02
- Peptides
- Inhibitor of nuclear factor kappa-B kinase subunit alpha: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GB
HC
ID
JE
KF
L